XML 66 R23.htm IDEA: XBRL DOCUMENT v3.20.4
Registered Offering and Warrants
12 Months Ended
Dec. 31, 2020
Equity [Abstract]  
Registered Offering and Warrants

16. Registered Offering and Warrants

 

On March 17, 2020, the Company closed a registered offering of 7,250,000 shares of the Company’s Class 2 common stock for $4.76 per share with an equal number of accompanying warrants and 11,750,000 pre-funded warrants for $4.7599 (the “pre-funded warrants”) with an equal number of accompanying warrants. The pre-funded warrants had an exercise price per share of Class 2 common stock of $0.0001 and were exercisable at any time after their original issuance and expire on the fifth anniversary date of issuance. As of December 31, 2020, all pre-funded warrants have been exercised. The 19,000,000 total accompanying warrants (the “warrants”) allow the holders to purchase an aggregate of 19,000,000 shares of the Company’s Class 2 common stock. The warrants have an exercise price per share of Class 2 common stock of $5.95 and are exercisable at any time after the first trading day following the six-month anniversary of the issuance and will expire on the fifth anniversary date from the date they become exercisable. As of December 31, 2020, the warrants remain outstanding.

 

The total gross proceeds of the registered offering were $90,439, of which $21,025 was allocated to the Class 2 common stock at the offering close and $69,414 was allocated to the warrant liability. Issuance costs incurred on the registered offering were $5,150, of which $3,953 was recorded to other expenses (income) in the statements of net loss and comprehensive loss and $1,197 was allocated to the Class 2 common stock and recorded net against the allocated gross proceeds in additional paid-in-capital.

 

The warrants contain anti-dilution price protection features, which adjust the exercise price of the warrants if the Company subsequently issues Class 2 common stock at a price lower than the exercise price of the warrants. In the event additional warrants or convertible debt are issued with a lower and/or variable exercise price, the exercise price of the warrants will be adjusted accordingly. There were no triggering events during the year ended December 31, 2020. The Company received stockholder approval of the anti-dilution price protection feature at the Company’s Annual Meeting on May 28, 2020.

 

The Company's warrants are classified as liabilities as they are to be settled in registered shares, and the registration statement is required to be active, unless such shares may be subject to an applicable exemption from registration requirements. The holders, at their sole discretion, may elect to effect a cashless exercise, and be issued exempt securities in accordance with Section 3(a)(9) of the 1933 Act. In the event the Company does not maintain an effective registration statement, the Company may be required to pay a daily cash penalty equal to 1% of the number of shares of Class 2 common stock due to be issued multiplied by any trading price of the Class 2 common stock between the exercise date and the share delivery date, as selected by the holder. Alternatively, the Company may deliver registered Class 2 common stock purchased by the Company in the open market. The Company may also be required to pay cash if it does not have sufficient authorized shares to deliver to the holders upon exercise.

 

Pre-funded warrants and warrants outstanding at December 31, 2020, and related activity for the year ended December 31, 2020 is as follows (reflects the number of shares of Class 2 common stock as if the warrants were converted to Class 2 common stock):

 

Description

 

Classification

 

Exercise price

 

 

Expiration date

 

Balance

December 31, 2019

 

 

Issued

 

 

Exercised

 

 

Balance

December 31, 2020

 

Pre-Funded Warrants

 

Liability

 

$

0.0001

 

 

March 17, 2025

 

 

 

 

 

11,750,000

 

 

 

(11,750,000

)

 

 

 

Warrants

 

Liability

 

$

5.95

 

 

March 17, 2025

 

 

 

 

 

19,000,000

 

 

 

 

 

 

19,000,000

 

 

 

 

 

 

 

 

 

Total

 

 

 

 

 

30,750,000

 

 

 

(11,750,000

)

 

 

19,000,000

 

 

The Company estimated the fair value of the Warrant liability at December 31, 2020 at $6.35 per warrant using the Monte Carlo pricing model (Level 3) with the following weighted-average assumptions:

 

Risk-free interest rate

 

 

0.40

%

Expected volatility

 

 

100

%

Expected term

 

4.7 years

 

Expected dividend yield

 

 

0

%

Strike price

 

$

5.95

 

Fair value of common stock

 

$

8.26

 

 

Expected volatility is based on both historical and implied volatility of the Company's common stock since its initial public offering in 2018.